Wolverine Trading, LLC Immunic, Inc. Put Options Transaction History

Wolverine Trading, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$1.08 - $1.95 $12,636 - $22,815	11,700 New	11,700 $19,000
Q3 2022 Nov 14, 2022	BUY	$3.0 - $5.49 $40,200 - $73,566	13,400 New	13,400 $42,000
Q2 2022 Aug 15, 2022	SELL	$3.13 - $12.25 $41,629 - $162,925	-13,300 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$9.54 - $14.26 $26,711 - $39,928	-2,800 Reduced 17.39%	13,300 $154,000
Q2 2021 Aug 06, 2021	BUY	$11.76 - $16.85 $189,336 - $271,285	16,100 New	16,100 $198,000

56.2M

100

350K

Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,565,000
Market Cap $33M
Description
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.